Pharmaceuticals, Biotechnology and Life Sciences
Mission Therapeutics today announced the appointment of Dr. James Summers asan independent member to its Board of Directors, with immediate effect.
First-Quarter 2019 Worldwide Sales Were $10.8 Billion, an Increase of8%; Sales Increased 11% Excluding Negative Impact from ForeignExchange; Growth Driven by Oncology and Vaccines
First-Quarter 2019 Revenues of $13.1 Billion, Reflecting 5% Operational Growth Driven by 7% Operational Growth from Pfizer Biopharmaceuticals Group and…
If approved, cabotegravir and rilpivirine would be the first-ever long-acting, injectable treatment regimen for adults living with HIV LONDON–(BUSINESS WIRE)–ViiV…
Seed will enable growth of the PolyProx team and furtherdevelop our technology over the next two years
Allotex has treated over 50 eyes in the first phase of its clinical trials.
DUBLIN–(BUSINESS WIRE)–The “Pharma Clinical Trial Digitization – Companies to Action, 2019” report has been added to ResearchAndMarkets.com’s offering. Despite the…
DUBLIN–(BUSINESS WIRE)–The “Global Erectile Dysfunction (ED) Drugs Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. The erectile dysfunction (ED)…
ULTOMIRIS has the potential to become the new standard of care forboth complement inhibitor-naïve patients and patients switching fromSOLIRIS (eculizumab) –
Based on the source, the market was dominated by the bacteria-basedprobiotic supplements segment, with a 91% share in 2017. Most probioticsupplements include bacterial strains, of which, Lactobacillus sp andBifidobacterium sp are used widely for the maintenance of healthymicrobiota.